D-0033-2016 Class III Terminated

Recalled by Ohm Laboratories, Inc. — North Brunswick, NJ

FDA drug recall D-0033-2016 was initiated by Ohm Laboratories, Inc. on Jul 28, 2015 and is designated Class III. Reason for recall: Superpotent Drug: Out Of Specification (OOS) result for Assay. The recall status is terminated (terminated Oct 28, 2016). Affected quantity: 11,232 boxes.

Recall details

Product Type
Drugs
Report Date
Oct 21, 2015
Initiation Date
Jul 28, 2015
Termination Date
Oct 28, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,232 boxes

Product description

Premier Value Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets per box; Distributed by Chain Drug Consortium, 3301 NW Boca Raton Blvd. Suite 101, Boca Raton, FL 33431, NDC 68016-527-31, UPC 8 4098601899 2

Reason for recall

Superpotent Drug: Out Of Specification (OOS) result for Assay.

Distribution pattern

Nationwide.

Code information

Batch Numbers: 2600126, Exp 2/29/2016; 2644273, Exp 9/30/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0033-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0033-2016. Report a data issue: hello@regdatalab.com.